Prebiotics increase iron absorption and reduce the adverse effects of iron on the gut microbiome and inflammation: a randomized controlled trial using iron stable isotopes in Kenyan infants.

Iron Kenya absorption fructo-oligosaccharides galacto-oligosaccharides gut inflammation gut microbiome infant iron stable isotopes prebiotic

Journal

The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027

Informations de publication

Date de publication:
30 Nov 2023
Historique:
received: 20 04 2023
revised: 18 11 2023
accepted: 27 11 2023
medline: 3 12 2023
pubmed: 3 12 2023
entrez: 2 12 2023
Statut: aheadofprint

Résumé

Iron fortificants tend to be poorly absorbed and may adversely affect the gut, especially in African children. We assessed the effects of prebiotic galacto-oligosaccharides/fructo-oligosaccharides (GOS/FOS) on iron absorption and gut health when added to iron-fortified infant cereal. We randomized Kenyan infants (n=191) to receive daily for 3 weeks a cereal containing iron and either 7.5g GOS/FOS (7.5g+iron group), 3g (3g+iron group) GOS/FOS, or no prebiotics (iron group). A subset of infants in the two prebiotic+iron groups (n=66) consumed 4 stable iron isotope labelled test meals without and with prebiotics, both before and after the intervention. Primary outcome was fractional iron absorption (FIA) from the cereal with or without prebiotics regardless of dose, before and after 3 weeks of consumption. Secondary outcomes included: fecal gut microbiota, iron and inflammation status, and effects of prebiotic dose. We registered the study at Clinicaltrials.gov(NCT03894358). Median(25th-75th percentiles) FIAs from meals before intervention were: 16.3%[8.0-27.6] without prebiotics versus 20.5%[10.4-33.4] with prebiotics (Cohen's d=0.53; P<0.001). FIA from the meal consumed without prebiotics after intervention was 22.9%[8.5-32.4], 41% higher than from the meal without prebiotics before intervention (Cohen's d=0.36; P=0.002). FIA from the meal consumed with prebiotics after intervention was 26.0%[12.2-36.1], 60% higher than from the meal without prebiotics before intervention (Cohen's d=0.45; P=0.007). After 3 weeks, compared to the iron group: (i) Lactobacillus abundances were higher in both prebiotic+iron groups (P<0.05); (ii) Enterobacteriaceae abundances (P=0.022) and the sum of pathogens (P<0.001) were lower in the 7.5g+iron group; (iii) the abundance of bacterial toxin-encoding genes was lower in the 3g+iron group (FDR<0.05); (iv) fecal pH (P<0.001) and calprotectin (P=0.033) were lower in the 7.5g+iron group. Adding prebiotics to iron-fortified infant cereal increases iron absorption and reduces the adverse effects of iron on the gut microbiome and inflammation in Kenyan infants.

Sections du résumé

BACKGROUND BACKGROUND
Iron fortificants tend to be poorly absorbed and may adversely affect the gut, especially in African children.
OBJECTIVE OBJECTIVE
We assessed the effects of prebiotic galacto-oligosaccharides/fructo-oligosaccharides (GOS/FOS) on iron absorption and gut health when added to iron-fortified infant cereal.
METHODS METHODS
We randomized Kenyan infants (n=191) to receive daily for 3 weeks a cereal containing iron and either 7.5g GOS/FOS (7.5g+iron group), 3g (3g+iron group) GOS/FOS, or no prebiotics (iron group). A subset of infants in the two prebiotic+iron groups (n=66) consumed 4 stable iron isotope labelled test meals without and with prebiotics, both before and after the intervention. Primary outcome was fractional iron absorption (FIA) from the cereal with or without prebiotics regardless of dose, before and after 3 weeks of consumption. Secondary outcomes included: fecal gut microbiota, iron and inflammation status, and effects of prebiotic dose. We registered the study at Clinicaltrials.gov(NCT03894358).
RESULTS RESULTS
Median(25th-75th percentiles) FIAs from meals before intervention were: 16.3%[8.0-27.6] without prebiotics versus 20.5%[10.4-33.4] with prebiotics (Cohen's d=0.53; P<0.001). FIA from the meal consumed without prebiotics after intervention was 22.9%[8.5-32.4], 41% higher than from the meal without prebiotics before intervention (Cohen's d=0.36; P=0.002). FIA from the meal consumed with prebiotics after intervention was 26.0%[12.2-36.1], 60% higher than from the meal without prebiotics before intervention (Cohen's d=0.45; P=0.007). After 3 weeks, compared to the iron group: (i) Lactobacillus abundances were higher in both prebiotic+iron groups (P<0.05); (ii) Enterobacteriaceae abundances (P=0.022) and the sum of pathogens (P<0.001) were lower in the 7.5g+iron group; (iii) the abundance of bacterial toxin-encoding genes was lower in the 3g+iron group (FDR<0.05); (iv) fecal pH (P<0.001) and calprotectin (P=0.033) were lower in the 7.5g+iron group.
CONCLUSIONS CONCLUSIONS
Adding prebiotics to iron-fortified infant cereal increases iron absorption and reduces the adverse effects of iron on the gut microbiome and inflammation in Kenyan infants.

Identifiants

pubmed: 38042412
pii: S0002-9165(23)66291-4
doi: 10.1016/j.ajcnut.2023.11.018
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT03894358']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Conflicts Of Interest MD, IK, GR and RBS are Danone Nutricia Research employees. Other authors have no conflict of interest.

Auteurs

Nadja Mikulic (N)

Laboratory of Human Nutrition, Department of Health Sciences and Technology, ETH Zurich, Switzerland.

Mary A Uyoga (MA)

Laboratory of Human Nutrition, Department of Health Sciences and Technology, ETH Zurich, Switzerland.

Nicole U Stoffel (NU)

Laboratory of Human Nutrition, Department of Health Sciences and Technology, ETH Zurich, Switzerland.

Muriel Derrien (M)

Danone Nutricia Research, Palaiseau, France.

Suzane Nyilima (S)

Public and Community Health Department, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.

Ioannis Kostopoulos (I)

Danone Nutricia Research, Utrecht, The Netherlands.

Guus Roeselers (G)

Danone Nutricia Research, Utrecht, The Netherlands.

Empar Chenoll (E)

Biopolis S.L.-ADM, 46980 Paterna, Spain.

Edith Mwasi (E)

Paediatrics Department, Msambweni County Referral Hospital, Msambweni, Kenya.

Giulia Pironaci (G)

Laboratory of Human Nutrition, Department of Health Sciences and Technology, ETH Zurich, Switzerland.

Simon Karanja (S)

Public and Community Health Department, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.

Raphaëlle Bourdet-Sicard (R)

Danone Nutricia Research, Palaiseau, France.

Michael B Zimmermann (MB)

Medical Research Council Translational Immune Discovery Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford. Electronic address: michael.zimmermann@rdm.ox.ac.uk.

Classifications MeSH